Mike Mitchell, PhD, Associate Professor of Bioengineering at Penn Engineering, was featured in Genetic Engineering & Biotechnology News for his research team’s discovery that lipid nanoparticles (LNPs) can be used to modify the metabolism of immune cells to enhance the efficacy of mRNA vaccines. Read more here.
To connect about partnership and investment opportunities, please contact Shilpa Bansali, PhD, Senior Associate Director of Licensing.